GobyMeds vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit TrimRx - our featured pick→or find your match

GobyMeds beats Novi overall, scoring 8.4/10 vs 7.8/10. Novi is more affordable at $133/mo vs $169/mo. Choose GobyMeds for budget-conscious users who want a modern, well-reviewed comp. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at GobyMeds and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

GobyMeds

#3 of 53

8.4/10

Fast-growing compounded GLP-1 provider with strong Reddit reviews, competitive pricing, and a clean user experience that punches above its price point.

Visit GobyMeds

Novi

#12 of 53

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Feature	GobyMeds	Novi
Our Score	8.4/10	7.8/10
Starting Price	$169/mo	$133/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Budget-conscious users who want a modern, well-reviewed compounded GLP-1 program	Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out for	Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story	Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking	#3	#12
Get started	Visit GobyMeds	Visit Novi

Pros & Cons Compared

GobyMeds

Pros

+$169/mo standard monthly rate, or $99/mo on the 3-month starter bundle, among the most affordable for a full-service compounded program
+Consistently positive Reddit reviews citing fast shipping, responsive support, and clean UX
+Modern patient portal with real-time order tracking and easy provider messaging
+Quick onboarding, most patients approved and shipped within 48 hours of enrollment

Cons

−Tirzepatide and brand-name options added 2026 but at much higher price points ($299/mo+), the semaglutide program is the value story
−Newer company with less track record than established players like Ro or Hims
−No insurance billing and no superbills for FSA/HSA reimbursement

Novi

Pros

+Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
+Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
+Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
+Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
+Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
+100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
−Founding year, headquarters city, and corporate ownership are not publicly disclosed
−Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
−Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

GobyMeds edges out Novi with a score of 8.4/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to GobyMeds's $169/mo. GobyMeds offers both brand-name and compounded medications, giving you more flexibility. Choose GobyMeds if you want: budget-conscious users who want a modern, well-reviewed compounded glp-1 program. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither GobyMeds nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review